CUTR · Cutera Inc - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - |
| Cost of Revenue | $30.69M | $26.73M | $26.37M | - | $40.02M | $33.16M | $30.07M | - | $28.56M | $29.18M |
| Gross Profit | $1.81M | $7.64M | $12.42M | - | $6.46M | $28.05M | $24.93M | - | $34.25M | $35.04M |
| R&D | $4.35M | $4.46M | $5.00M | - | $4.59M | $5.78M | $6.47M | - | $6.39M | $6.86M |
| SG&A | $14.75M | $4.32M | $12.88M | - | $17.00M | $18.53M | $12.52M | - | $10.80M | $11.25M |
| Total Operating Expenses | $38.03M | $29.45M | $31.85M | - | $47.40M | $57.58M | $48.50M | - | $43.68M | $45.11M |
| D&A | - | - | - | - | $1.20M | $1.07M | $1.08M | - | - | - |
| Operating Income | ($36.22M) | ($21.80M) | ($19.43M) | - | ($40.95M) | ($29.53M) | ($23.57M) | - | ($9.43M) | ($10.06M) |
| Interest Expense | $3.07M | $2.96M | $2.94M | - | $2.94M | $2.96M | $2.94M | - | $1.74M | $1.15M |
| Income Tax | $493.0K | ($19.0K) | ($25.0K) | - | $167.0K | $326.0K | $272.0K | - | $827.0K | ($186.0K) |
| Net Income | ($39.02M) | ($24.68M) | ($22.78M) | - | ($44.27M) | ($31.64M) | ($25.02M) | - | ($12.13M) | ($47.28M) |
| EPS - Basic | ($1.94) | ($1.23) | ($1.14) | - | ($2.22) | ($1.59) | ($1.26) | - | ($0.62) | ($2.53) |
| EPS - Diluted | ($1.94) | ($1.23) | ($1.14) | - | ($2.22) | ($1.59) | ($1.26) | - | ($0.62) | ($2.53) |
Balance Sheet
| Line item | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $57.61M | $83.11M | $105.44M | $143.61M | $179.52M | $180.65M | $166.83M | $145.92M | $45.88M | $75.05M |
| Accounts Receivable | $33.15M | $34.55M | $37.02M | $43.12M | $49.83M | $53.08M | $52.14M | $45.56M | $35.88M | $32.15M |
| Inventory | $56.91M | $80.35M | $73.47M | $62.60M | $61.85M | $68.67M | $71.82M | $63.63M | $55.94M | $45.41M |
| Accounts Payable | $7.95M | $17.62M | $13.32M | $19.83M | $31.37M | $34.24M | $35.17M | $33.74M | $34.18M | $25.36M |
| Current Assets | $160.51M | $210.98M | $235.23M | $269.19M | $311.31M | $369.95M | $418.46M | $451.24M | $366.31M | $373.31M |
| Total Assets | $234.42M | $276.30M | $311.99M | $346.29M | $406.63M | $463.83M | $499.80M | $520.99M | $428.16M | $424.09M |
| Current Liabilities | $55.69M | $60.15M | $72.70M | $87.75M | $92.41M | $103.06M | $108.79M | $105.84M | $98.26M | $85.72M |
| Long-term Debt | - | - | - | - | - | - | - | - | - | - |
| Total Liabilities | $487.29M | $491.97M | $504.56M | $518.12M | $522.72M | $532.97M | $538.81M | $536.17M | $412.66M | $400.22M |
| Stockholders' Equity | ($252.87M) | ($215.67M) | ($192.56M) | ($171.83M) | ($116.08M) | ($69.14M) | ($39.01M) | ($15.18M) | $15.49M | $23.87M |
| Retained Earnings | ($389.82M) | ($350.81M) | ($326.12M) | ($303.35M) | ($246.11M) | ($197.17M) | ($165.53M) | ($140.51M) | ($132.72M) | ($120.59M) |
Cash Flow
| Line item | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | ($37.63M) | - | - | - | ($37.06M) | - | - | - |
| Investing Cash Flow | - | - | ($278.0K) | - | - | - | $60.38M | - | - | - |
| Financing Cash Flow | - | - | ($260.0K) | - | - | - | ($2.41M) | - | - | - |
| CapEx | - | - | $335.0K | - | - | - | $11.15M | - | - | - |
| Free Cash Flow | - | - | ($37.97M) | - | - | - | ($48.22M) | - | - | - |
Ratios
| Metric | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | - | - | - | - | - | - | - | - | - | - |
| Operating margin | - | - | - | - | - | - | - | - | - | - |
| EBITDA margin | - | - | - | - | - | - | - | - | - | - |
| Net margin | - | - | - | - | - | - | - | - | - | - |
| Free cash flow margin | - | - | - | - | - | - | - | - | - | - |
| FCF / Net income | - | - | 1.67 | - | - | - | 1.93 | - | - | - |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | - | - | - | - | - | - | - | - | - | - |
| Effective tax rate | - | - | - | - | - | - | - | - | - | - |
| Return on assets | -16.6% | -8.9% | -7.3% | - | -10.9% | -6.8% | -5.0% | - | -2.8% | -11.1% |
| Return on equity | 15.4% | 11.4% | 11.8% | - | 38.1% | 45.8% | 64.1% | - | -78.3% | -198.0% |
| Return on invested capital | - | - | - | - | - | - | - | - | - | - |
| Liquidity | ||||||||||
| Current ratio | 2.88 | 3.51 | 3.24 | 3.07 | 3.37 | 3.59 | 3.85 | 4.26 | 3.73 | 4.36 |
| Quick ratio | 1.86 | 2.17 | 2.22 | 2.35 | 2.70 | 2.92 | 3.19 | 3.66 | 3.16 | 3.83 |
| Cash ratio | 1.03 | 1.38 | 1.45 | 1.64 | 1.94 | 1.75 | 1.53 | 1.38 | 0.47 | 0.88 |
| Leverage | ||||||||||
| Debt / Equity | - | - | - | - | - | - | - | - | - | - |
| Debt / Assets | - | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest coverage | -11.8x | -7.4x | -6.6x | - | -13.9x | -10.0x | -8.0x | - | -5.4x | -8.8x |
| Equity multiplier | -0.93 | -1.28 | -1.62 | -2.02 | -3.50 | -6.71 | -12.81 | -34.32 | 27.63 | 17.76 |
| Liabilities / Assets | 2.08 | 1.78 | 1.62 | 1.50 | 1.29 | 1.15 | 1.08 | 1.03 | 0.96 | 0.94 |
| Efficiency | ||||||||||
| Asset turnover | - | - | - | - | - | - | - | - | - | - |
| Inventory turnover | 0.54 | 0.33 | 0.36 | - | 0.65 | 0.48 | 0.42 | - | 0.51 | 0.64 |
| Days sales outstanding | - | - | - | - | - | - | - | - | - | - |
| Days inventory outstanding | 677d | 1097d | 1017d | - | 564d | 756d | 872d | - | 715d | 568d |
| Days payable outstanding | 95d | 241d | 184d | - | 286d | 377d | 427d | - | 437d | 317d |
| Cash conversion cycle | - | - | - | - | - | - | - | - | - | - |
| Valuation | ||||||||||
| P / E | - | - | - | - | - | - | - | - | - | - |
| P / B | - | - | - | - | - | - | - | - | - | - |
| P / S | - | - | - | - | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Growth | ||||||||||
| Revenue growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| Revenue CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| Revenue CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Gross profit growth (YoY) | -71.9% | -72.8% | -50.2% | - | -81.1% | -19.9% | -21.6% | - | 2.5% | 3.7% |
| Operating income growth (YoY) | 11.6% | 26.2% | 17.6% | - | -334.1% | -193.4% | -79.1% | - | - | - |
| Net income growth (YoY) | 11.9% | 22.0% | 8.9% | - | -264.9% | 33.1% | -65.2% | - | -772.9% | - |
| EPS growth (YoY) | 12.6% | 22.6% | 9.5% | - | -258.1% | 37.2% | -50.0% | - | -675.0% | - |
| EPS CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| FCF growth (YoY) | - | - | 21.3% | - | - | - | -61.1% | - | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | -117.8% | -212.0% | -393.6% | -1031.9% | - | - | - | - | -72.0% | -55.2% |
Peer comparison
Same SIC group: Electromedical & Electrotherapeutic Apparatus
Comparing CUTERA INC against the 5 most active filers in the same SIC group.